Pyramid Formulations Private Limited
About Pyramid Formulations Private Limited
Data last updated:
Pyramid Formulations Private Limited is a private limited company based in Salem, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 April 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U24232TZ2012PTC018136. Its GSTIN is 33AAGCP6774P1ZO (Tamil Nadu).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mani Krishnamoorthy (Managing Director) and Krishnamoorthy Gayathri.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at S3 Kurinji Kudil Saral Village Alagapuram Fairlands Po, Salem, Tamil Nadu, India – 636016.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.14 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹11,586 (net margin 0.1%) and EBITDA of ₹3.04 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressS3 Kurinji Kudil Saral Village Alagapuram Fairlands Po, Salem, Tamil Nadu, India – 636016
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pyramid Formulations Private Limited
The main business activity of Pyramid Formulations is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pyramid Formulations Private Limited FY 2023 filings available
Pyramid Formulations Private Limited reported revenue of ₹1.14 Cr (up 16% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Pyramid Formulations Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 16% growth in the latest year. EBITDA rose 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pyramid Formulations Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.04 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹11,586 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pyramid Formulations Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pyramid Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pyramid Formulations Private Limited
Pyramid Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pazia Pharmaceuticals Private Limited | ₹1.14 Cr (FY 2025) | •••• | •••• | 820.0% | •••• | Jaipur, Rajasthan, India |
| Apn Biotech Private Limited | ₹1.14 Cr (FY 2025) | •••• | •••• | 563.0% | •••• | Noida, Uttar Pradesh, India |
| Osr Pharmaceuticals Private Limited | ₹1.14 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Delhi, India |
| Vrihad Health Care Private Limited | ₹1.14 Cr (FY 2024) | •••• | •••• | 66.0% | •••• | Chhattisgarh, India |
| Vmedicare Private Limited | ₹1.14 Cr (FY 2024) | •••• | •••• | 295.0% | •••• | Kalyan, Maharashtra, India |
| Pyramid Formulations Private Limited this company | ₹1.14 Cr (FY 2023) | •••• | •••• | 16.0% | •••• | Salem, Tamil Nadu, India |
| Life Line Biotech Limited | ₹1.14 Cr (FY 2025) | •••• | •••• | -66.0% | •••• | New Delhi, Delhi, India |
| Ytiliga Private Limited | ₹1.14 Cr (FY 2024) | •••• | •••• | 30.0% | •••• | Delhi, India |
| Inspride Lab Private Limited | ₹1.14 Cr (FY 2019) | •••• | •••• | 82.0% | •••• | Raipur, Chhattisgarh, India |
| Kapsin Pharma Private Limited | ₹1.14 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Ahmedabad, Gujarat, India |
| Medixfora Healthcare Private Limited | ₹1.14 Cr (FY 2025) | •••• | •••• | -31.0% | •••• | Gurgaon, Haryana, India |
Peers are the five companies nearest above and the five nearest below Pyramid Formulations by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pyramid Formulations Private Limited
Auditor information for Pyramid Formulations Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of Pyramid Formulations Private Limited
Pyramid Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mani Krishnamoorthy | Managing Director | 17 Apr 2012 | 14 Years 5 Months | Current |
| Krishnamoorthy Gayathri | Director | 17 Apr 2012 | 14 Years 5 Months | Current |
Ownership and Shareholding of Pyramid Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pyramid Formulations Private Limited
Pyramid Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Pyramid Formulations Private Limited
Employment history and EPFO contributions of people linked to Pyramid Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pyramid Formulations Private Limited
Pyramid Formulations Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Krishnamoorthy Gayathri was appointed as Director on 17 Apr 2012.
Credit Ratings, Litigation & Regulatory Alerts for Pyramid Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pyramid Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pyramid Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pyramid Formulations Private Limited
Pyramid Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAGCP6774P1ZO | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pyramid Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pyramid Formulations Private Limited
Pyramid Formulations is an active private limited company based in Salem, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 April 2012 (14+ years old) and is registered under CIN U24232TZ2012PTC018136.
Pyramid Formulations reported revenue of ₹1.14 Cr for FY 2023 (up 16% YoY).
Pyramid Formulations has 2 current directors:
- Mani Krishnamoorthy - Managing Director
- Krishnamoorthy Gayathri - Director
Pyramid Formulations reported a net profit of ₹11,586 (net margin 0.1%) and EBITDA of ₹3.04 Lakh (EBITDA margin 2.7%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pyramid Formulations is 7% over three years and 9% over five years. In the latest year (FY 2023) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pyramid Formulations is 33AAGCP6774P1ZO, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Pyramid Formulations is U24232TZ2012PTC018136. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pyramid Formulations was incorporated on 17 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Pyramid Formulations by revenue are Pazia Pharmaceuticals Private Limited, Apn Biotech Private Limited, Osr Pharmaceuticals Private Limited, Vrihad Health Care Private Limited, Vmedicare Private Limited and 5 more, all in the Pharma industry (Formulations, Pharma Retail and Distribution).
Krishnamoorthy Gayathri was appointed as Director on 17 Apr 2012. Mani Krishnamoorthy was appointed as Managing Director on 17 Apr 2012.
The registered office of Pyramid Formulations is at S3 Kurinji Kudil Saral Village Alagapuram Fairlands Po, Salem, Tamil Nadu, India – 636016.